Bevacizumab/Carboplatin/Gemcitabine Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C160552
A chemotherapy regimen consisting of gemcitabine, carboplatin, and bevacizumab that may be used in the treatment of ovarian, fallopian tube, or primary peritoneal cancer. [ ]
Term info
Label
Bevacizumab/Carboplatin/Gemcitabine Regimen
Synonyms
- Avastin/Paraplatin/Gemzar
- Bevacizumab/Carboplatin/Gemcitabine
- Bevacizumab/Carboplatin/Gemcitabine Regimen
- GC + Bev
- GC Plus Bev
- Gemcitabine/Carboplatin/Bevacizumab
- Gemcitabine/Carboplatin/Bevacizumab Regimen
Subsets
NCIT_C160952, NCIT_C160950
Preferred Name
Bevacizumab/Carboplatin/Gemcitabine Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C160552
Term relations
Subclass of:
- Regimen Used to Treat Malignant Ovarian Neoplasm
- Regimen Used to Treat Malignant Peritoneal Neoplasm
- Regimen Used to Treat Malignant Fallopian Tube Neoplasm
- Chemotherapy_Regimen_Has_Component some Carboplatin
- Chemotherapy_Regimen_Has_Component some Gemcitabine Hydrochloride
- Chemotherapy_Regimen_Has_Component some Bevacizumab